New study points to a strategy for inhibiting hyper-progression of melanoma


Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

The Gozney Dome is so much more than a pizza oven

Previous article

Save 67% on Kindle Unlimited this Black Friday

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News